Relationships of PPARγ and PPARγ2 mRNA levels to obesity, diabetes and hyperinsulinaemia in rhesus monkeys

International Journal of Obesity

Volumn 22, Issue 10, 1998, Pages 1000-1010

  Hotta, K ^a   Gustafson, T A ^a   Yoshioka, S ^a   Ortmeyer, H K ^a   Bodkin, N L ^a   Hansen, B C ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

AF033103; AF033342 PPAR 1 b; AF033343, PPAR 2; Gene expression; Obesity; PPAR ; Rhesus monkey GenBank accession number: PPAR 1 a

Indexed keywords

BINDING PROTEIN; COMPLEMENTARY DNA; GLUCOSE; GLUCOSE TRANSPORTER; INSULIN; LIPOPROTEIN LIPASE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; CCAAT ENHANCER BINDING PROTEIN; CELL RECEPTOR; DNA BINDING PROTEIN; GLUCOSE TRANSPORTER 4; MUSCLE PROTEIN; NUCLEAR PROTEIN; SLC2A4 PROTEIN, HUMAN; SLC2A4 PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CORRELATION FUNCTION; GENE EXPRESSION; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; MOLECULAR CLONING; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL; RHESUS MONKEY; TISSUE DISTRIBUTION; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; GENETICS; HUMAN; HYPERINSULINISM; MACACA; METABOLISM; MOLECULAR GENETICS; MOUSE; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY;

ADIPOSE TISSUE; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CCAAT-ENHANCER-BINDING PROTEINS; DIABETES MELLITUS, TYPE 2; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; GLUCOSE TRANSPORTER TYPE 4; HUMANS; HYPERINSULINISM; LIPOPROTEIN LIPASE; MACACA MULATTA; MICE; MOLECULAR SEQUENCE DATA; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE PROTEINS; NUCLEAR PROTEINS; OBESITY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEQUENCE HOMOLOGY; TRANSCRIPTION FACTORS;

EID: 0032185630     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0800718     Document Type: Article

References (51)

1. Hansen BC, Bodkin NL. Heterogeneity of insulin responses: phases leading to type 2 (non-insulin-dependent) diabetes mellitus in the rhesus monkey. Diabetologia 1986; 29: 713-719.
2. Bodkin NL, Metzger BL, Hansen BC. Hepatic glucose production and insulin sensitivity preceding diabetes in monkeys. Am J Physiol 1989; 256: E676-E681.
3. Jen KLC, Hansen BC, Metzger BL. Adiposity, anthropometric measures, and plasma insulin levels of rhesus monkeys. Int J Obes 1985; 9: 213-224.
4. Ailhaud G, Grimaldi P, Negrel R. Cellular and molecular aspects of adipose tissue development. Annu Rev Nutr 1992; 12: 207-233.
5. MacDougald OA, Lane MD. Transcriptional regulation of gene expression during adipocyte differentiation. Annu Rev Biochem 1995; 64: 345-373.
6. Spiegelman BM, Flier JS. Adipogenesis and obesity: rounding out the big picture. Cell 1996; 87: 377-389.
7. Zhu Y, Qi C, Korenberg JR, Chen XN, Noya D, Rao MS, Reddy JK. Structural organization of mouse peroxisome proliferator-activated receptor γ (mPPARγ) gene: alternative promoter use and different splicing yield two mPPARγ isoforms. Proc Natl Acad Sci USA 1995; 92: 7921-7925.
8. Zhu Y, Alvares K, Huang Q, Rao MS, Reddy JK. Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver. J Biol Chem 1993; 268: 26817-26820.
9. Chen F, Law SW, O'Malley BW. Identification of two mPPAR related receptors and evidence for the existence of five subfamily members. Biochem Biophys Res Commun 1993; 196: 671-677.
10. Tontonoz P, Hu E, Graves RA, Budavari AI, Spiegelman BM. mPPARγ2: tissue-specific regulator of an adipocyte enhancer. Genes & Dev 1994; 8: 1224-1234.
11. Chawla A, Schwarz EJ, Dimaculangan DD, Lazar MA. Peroxisome proliferator-activated receptor (PPAR) γ: adipose-predominant expression and induction early in adipocyte differentiation. Endocrinol 1994; 135: 798-800.
12. Vidal-Puig A, Jimenez-Liñan M, Lowell BB, Hamann A, Hu E, Spiegelman B, Flier JS, Moller DE. Regulation of PPARγ gene expression by nutrition and obesity in rodents. J Clin Invest 1996; 97: 2553-2561.
13. Tontonoz P, Hu E, Spiegelman BM. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 1994; 79: 1147-1156.
14. Hu E, Tontonoz P, Spiegelman BM. Transdifferentiation of myoblasts by the adipogenic transcription factors PPARγ and C/EBPα. Proc Natl Acad Sci USA 1995; 92: 9856-9860.
15. Tontonoz P, Graves RA, Budavari AI, Erdjument-Bromage H, Lui M, Hu E, Tempst P, Spiegelman BM. Adipocyte-specific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPARγ and RXRα. Nucleic Acids Res 1994; 22: 5628-5634.
16. Tontonoz P, Hu E, Devine J, Beale EG, Spiegelman BM. PPARγ2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Mol Cell Biol 1995; 15: 351-357.
17. Green S, Wahli W. Peroxisome proliferator-activated receptors: finding the orphan a home. Mol Cell Endocrinol 1994; 100: 149-153.
18. Chawla A, Lazar MA. Perosixome proliferator and retinoid signaling pathways co-regulate preadipocyte phenotype and survival. Proc Natl Acad Sci USA 1994; 91: 1786-1790.
19. 2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell 1995; 83: 813-819.
20. 2 is a ligand for the adipocyte determination factor PPARγ. Cell 1995; 83: 803-812.
21. Lehmann JM, Moore LB, Smith-Oliver TA, Wilkison WO, Willson TM, Kliewer SA. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). J Biol Chem 1995; 270: 12953-12956.
22. Saltiel AR, Olefsky JM. Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 1996; 45: 1661-1669.
23. Vidal-Puig AJ, Considine RV, Jimenez-Liñan M, Werman A, Portes WJ, Caro JF, Flier JS. Peroxisome proliferator-activated receptor gene expression in human tissues: effects of obesity, weight loss, and regulation by insulin and glucocorticoids. J Clin Invest 1997; 99: 2416-2422.
24. Bodkin NL, Hannah JS, Ortmeyer HK, Hansen BC. Central obesity in rhesus monkeys: association with hyperinsulinemia, insulin resistance and hypertriglyceridemia? Int J Obes 1993; 17: 53-61.
25. Elbrecht A, Chen Y, Culliman CA, Hayes N, Leibowitz MD, Moller DE, Berger J. Molecular cloning, expression and characterization of human peroxisome proliferator activated receptors γ1 and γ2. Biochem Biophys Res Commun 1996; 224: 431-437.
26. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual (2nd edn). Cold Spring Harbor Laboratory Press: New York, 1989, pp 7.39-7.57.
27. Hotta K, Gustafson TA, Ortmeyer HK, Bodkin NL, Nicolson MA, Hansen BC. Regulation of obese (ob) mRNA and plasma leptin levels in rhesus monkeys: effects of insulin, body weight, and non-insulin-dependent diabetes mellitus. J Biol Chem 1996; 271: 25327-25331.
28. Antonson P, Xanthopoulos KG. Molecular cloning, sequence, and expression patterns of the human gene encoding CCAAT/enhancer binding protein α (C/EBPγ). Biochem Biophys Res Commun 1995; 215: 106-113.
29. Wion KL, Kirchgessner TG, Lusis AJ, Schotz MC, Lawn RM. Human lipoprotein lipase complimentary DNA sequence. Science 1987; 235: 1638-1641.
30. Fukumoto H, Kayano T, Buse JB, Edwards Y, Pilch PF, Bell GI, Seino S. Cloning and characterization of the major insulin-responsive glucose transporter expressed in human skeletal muscle and other insulin-responsive tissues. J Biol Chem 1989; 264: 7776-7779.
31. Bernlohr DA, Angus CW, Lane MD, Bolanowski MA, Kelly TJ Jr. Expression of specific mRNAs during adipose differentiation: identification of an mRNA encoding a homologue of myelin P2 protein. Proc Natl Acad Sci USA 1984; 81: 5468-5472.
32. Stoffel M, Xiang KS, Espinosa R III, Cox NJ, Le Beau MM, Bell GI. cDNA sequence and localization of polymorphic human cytosolic phosphoenolpyruvate carboxykinase gene (PCK1) to chromosome 20, band q13.31: PCK1 is not tightly linked to maturity-onset diabetes of the young. Hum Mol Genet 1993; 2: 1-4.
33. Wade R, Sutherland C, Gahlmann R, Kedes L, Hardeman E, Gunning P. Regulation of contractile protein gene family mRNA pool sizes during myogenesis. Dev Biol 1990; 142: 270-282.
34. Huang Z, Bodkin NL, Ortmeyer HK, Hansen BC. Shuldiner AR. Hyperinsulinemia is associated with altered insulin receptor mRNA splicing in muscle of the spontaneously obese diabetic rhesus monkey. J Clin Invest 1994; 94: 1289-1296.
35. Hayashi M, Floyd JC Jr, Pek S, Fajans SS. Insulin, proinsulin, glucagon and gastrin in pancreatic tumors and in plasma of patients with organic hyperinsulinism. J Clin Endocrinol Metab 1977; 44: 681-694.
36. Pace N, Kline L, Schachman HK, Harfenist M. Studies on body composition. IV. Use of radioactive hydrogen for measurement in vivo of total body water. J Biol Chem 1947; 168: 459-469.
37. Mukherjee R, Jow L, Croston GE, Paterniti JR Jr. Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARγ2 versus PPARγ1 and activation with retinoid X receptor agonists and antagonists. J Biol Chem 1997; 272; 8071-8076.
38. Zhang B, Berger J, Hu E, Szalkowski D, White-Carrington S, Spiegelman BM, Moller DE. Negative regulation of peroxisome proliferator-activated receptor-γ gene expression contributes to the antiadipogenic effects of tumor necrosis factor-α. Mol Endocrinol 1996; 10: 1457-1466.
39. Hainault I, Guerre-Millo M, Guichard C, Lavau M. Differential regulation of adipose tissue glucose transporters in genetic obesity (fatty rat): selective increase in the adipose cell/muscle glucose transporter (GLUT4) expression. J Clin Invest 1991; 87: 1127-1131.
40. Dugail I, Quignard-Boulangé A, Le Liepvre X, Ardouin B, Lavau M. Gene expression of lipid storage-related enzymes in adipose tissue of the genetically obese Zucker rat. Biochem J 1992; 281: 607-611.
41. Shimomura I, Tokunaga K, Jiao S, Funahashi T, Keno Y, Kobatake T, Kotani K, Suzuki H, Yamamoto T, Tarui S, Matsuzawa Y. Marked enhancement of acyl-CoA synthetase activity and mRNA, paralleled to lipoprotein lipase mRNA, in adipose tissues of Zucker obese rats (fa/fa). Biochim Biophys Acta 1992; 1124: 112-118.
42. Shimomura I, Takahashi M, Tokunaga K, Keno Y, Nakamura T, Yamashita S. Takemura K, Yamamoto T, Funahashi T, Matsuzawa Y. Rapid enhancement of acyl-CoA synthetase, LPL, and GLUT4 mRNAs in adipose tissue of VMII rats. Am J Physiol 1996; 270: E995-E1002.
43. Rolland V, Le Liepvre X, Houbiguian ML, Lavau M, Dugail I. C/EBPα expression in adipose tissue of genetically obese Zucker rats. Biochem Biophys Res Commun 1995; 207: 761-767.
44. Stephens JM, Pekala PH. Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-*. J Biol Chem 1991; 266: 21839-21845.
45. Stephens JM, Pekala PH. Transcriptional repression of the C/EBP-α and GLUT4 genes in 3T3-L1 adipocytes by tumor necrosis factor-α: regulation is coordinate and independent of protein synthesis. J Biol Chem 1992; 267: 13580-13584.
46. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 1993; 259: 87-91.
47. Yeh WC, Cao Z, Classon M, McKnight SL. Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes & Dev 1995; 9: 168-181.
48. Kim JB, Spiegelman BM. ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes & Dev 1996; 10: 1096-1107.
49. Bodkin NL, Ortmeyer HK, Hansen BC. Diversity of insulin resistance in monkeys with normal glucose tolerance. Obes Res 1993; 1: 364-370.
50. Després JP, Nadeau A, Tremblay A, Ferland M, Moorjani S, Lupien PJ, Thériault G, Pinault S, Bouchard C. Role of deep abdominal fat in the association between regional adipose tissue distribution and glucose tolerance in obese women. Diabetes 1989; 38: 304-309.
51. Fujioka S, Matsuzawa Y, Tokunaga K, Tarui S, Contribution of intra-abdommal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 1987; 36: 54-59.